Medical Communications

Showing 15 posts of 6408 posts found.

Health Canada announce first full approval for Moderna COVID-19 vaccine

September 17, 2021 Medical Communications AstraZeneca, BioNTech, Health Canada, Moderna, Pfizer, mrna

Canada has become the first country in the world to grant full approval to the Moderna vaccine, alongside confirmation for …

Researchers develop AI algorithm to diagnose deep vein thrombosis

September 16, 2021 Medical Communications, Research and Development

Researchers from the University of Oxford, Imperial College, and the University of Sheffield have developed a machine learning algorithm with …

Menstrual changes after COVID jab must be investigated, says leading immunologist

September 16, 2021 Medical Communications

Changes to periods and unexpected vaginal bleeding has been reported by 30,000 women to UK regulators, and now leading immunologist …

COVID deaths among fully vaccinated rare, ONS data finds

September 15, 2021 Medical Communications, Research and Development

New figures from the Office for National Statistics (ONS) show that fully vaccinated people are far less likely to die …

Sajid Javid: Valneva COVID vaccine would not have been approved by MHRA

September 15, 2021 Manufacturing and Production, Medical Communications, Research and Development

On Monday the UK cancelled a deal with French vaccine maker Valneva worth up to €1.4 billion, and Health Secretary …

Israeli survey finds 1 in 10 children have long COVID

September 14, 2021 Medical Communications, Research and Development

An Israeli Health Ministry survey has found that one in ten children have lingering COVID-19 symptoms after contracting and recovering …

NICE recommends Pfizer’s Xeljanz for juvenile idiopathic arthritis

September 10, 2021 Medical Communications

NICE has published final draft guidance recommending the use of Pfizer’s Xeljanz (tofacitinib) as an option for treating active polyarticular …

Pfizer and AstraZeneca approved as booster COVID vaccines

September 10, 2021 Medical Communications

The MHRA has approved the use of Pfizer and AstraZeneca’s COVID-19 vaccines for the planned booster programme this winter. However, …
nhs_old_hospital_1

NHS lung cancer patients to receive Amgen’s tumour-stopping drug

September 10, 2021 Medical Communications, Research and Development

NHS patients will be the first in Europe to receive a new drug that can prevent lung cancer tumour growth, …

FDA grants Fast Track Designation for Vor Biopharma’s AML drug

September 10, 2021 Medical Communications, Research and Development

Vor Biopharma has announced that the FDA has granted their acute myeloid leukemia (AML) engineered hematopoietic stem cell therapy (eHSC), …

Trials of former Theranos CEO Elizabeth Holmes are underway

September 8, 2021 Medical Communications, Research and Development

The highly anticipated trials of Elizabeth Holmes, founder and former CEO of the now-defunct Theranos, have commenced. Prosecutors are to …

Wider use of SGLT2 inhibitors for CVD recommended by NICE

September 7, 2021 Manufacturing and Production, Medical Communications

NICE has updated its guidelines on the management of type 2 diabetes, recommending wider use of SGLT2 inhibitors in those …

FDA halts BioMarin’s PKU gene therapy trial

September 7, 2021 Manufacturing and Production, Medical Communications, Research and Development

BioMarin Pharma has announced that the FDA has slapped a clinical hold on its Phase 1/2 trial of its candidate …

Sinovac booster jab reverses antibody drop from Delta variant, study finds

September 6, 2021 Medical Communications, Research and Development, Sales and Marketing

Researchers have found that a booster shot of Sinovac’s COVID-19 vaccine reverses a decline in antibody activities against the Delta …

COVID vaccine passports to start in England this month

September 6, 2021 Medical Communications, Sales and Marketing

The Vaccine Minister, Nadhim Zahawi, has confirmed that vaccine passports will be required in nightclubs and other indoor venues at …
The Gateway to Local Adoption Series

Latest content